- NCT00210860
- Primary Citation Trial has yet to be published
- Data Specification Not Available
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment142% FemaleN/A% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberCAPSS-296Data PartnerJohnson & JohnsonCondition StudiedMigraine DisordersMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available